Naoyuki Miyokawa

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

Shiro Yokohama, Masashi Yoneda, Masakazu Haneda et al. · Hepatology · 2004 · 459 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

Yoshinobu Ohsaki, Satoshi Tanno, Yasuko Fujita et al. · Oncology Reports · 2000 · 255 citations

Medicine, Cancer Biology, Oncology +14

HLA Class I Antigen Down-regulation in Primary Laryngeal Squamous Cell Carcinoma Lesions as a Poor Prognostic Marker

Takeshi Ogino, Hiroshi Shigyo, Hideyuki Ishii et al. · Cancer Research · 2006 · 190 citations · Full text

Medicine, Immunology, Oncology +16

Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas.

Hiroaki Fujii, Masaru Inagaki, S. Kasai et al. · PubMed · 1997 · 124 citations

Medicine, Oncology, Pathology +14

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

Shiro Yokohama, Yoshihiko Tokusashi, Kimihide Nakamura et al. · World Journal of Gastroenterology · 2006 · 104 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15